📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
47 announcements match the current filters (relevance ≥ 5).
KIMS to Invest ₹100 Crore to Increase Stake in Subsidiary Sarvejana Healthcare
The Board of KIMS has approved an additional investment of up to ₹100 Crores to acquire further shares in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital). KIMS currently holds a 75.53% stake in the subsidiary, which is a leading orthopedic and multi-specialty hospital in Hyderabad. Sunshine Hospital has shown strong growth, with its turnover increasing from ₹419.44 Crores in FY23 to ₹597.00 Crores in FY25. This strategic move aims to consolidate ownership in a high-performing asset through cash transactions with minority shareholders.
Key Highlights
Board approved ₹100 Crores for acquiring additional equity from minority shareholders in Sarvejana Healthcare.
KIMS currently owns 75.53% of Sarvejana Healthcare (Sunshine Hospital).
Sunshine Hospital reported a turnover of ₹597.00 Crores for FY25, up from ₹464.20 Crores in FY24.
The acquisition will be executed in one or more tranches based on independent valuation.
Sunshine Hospital is a key asset specializing in orthopedics, cardiology, and transplants.
👀 What to Watch
Investors should view this as a positive consolidation of a high-growth subsidiary that strengthens KIMS's market position in the Hyderabad healthcare sector. Monitor the final acquisition price and the resulting increase in consolidated net profit attributable to the parent company.
KIMS to Invest ₹100 Crore to Increase Stake in Subsidiary Sarvejana Healthcare
The Board of KIMS has approved an additional investment of up to ₹100 Crores to acquire further shares from minority shareholders in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital). KIMS currently holds a 75.53% stake in the subsidiary, which is a leading orthopedic-focused hospital in Hyderabad. The subsidiary has shown robust growth, with turnover increasing from ₹419.44 Crores in FY23 to ₹597.00 Crores in FY25. This strategic move aims to consolidate ownership in a high-performing asset through cash-based transactions in multiple tranches.
Key Highlights
Approved ₹100 Crore limit for acquiring additional equity from minority shareholders in Sarvejana Healthcare.
Current stake in the subsidiary stands at 75.53%, with the acquisition intended to further enhance control.
Sunshine Hospital reported a significant turnover growth to ₹597.00 Crores in FY25 from ₹464.20 Crores in FY24.
The acquisition will be completed in one or more tranches based on independent valuation.
Sunshine Hospital is a key revenue driver specializing in orthopedics, cardiology, and transplants.
👀 What to Watch
Investors should view this as a positive strategic consolidation of a profitable and growing subsidiary. The increased stake will likely lead to higher earnings accretion for KIMS shareholders in the long term.
KIMS Shareholders Approve Material RPT with Bengaluru Subsidiary with 93.18% Majority
Krishna Institute of Medical Sciences (KIMS) has successfully passed a resolution via postal ballot to approve a material related party transaction with its subsidiary, KIMS Hospital Bengaluru Private Limited. The resolution received 93.18% support from the total votes polled, ensuring the company can proceed with its internal financial and operational arrangements. While promoters and non-institutional public shareholders showed near-unanimous support, approximately 12.75% of institutional votes were cast against the proposal. This approval is a necessary step for the company's integrated operations and expansion in the Bengaluru region.
Key Highlights
Resolution for Material Related Party Transaction with KIMS Hospital Bengaluru Private Limited passed with 93.18% majority.
Total of 31.85 crore votes were polled, representing a 79.61% turnout of the total shareholding.
Public institutional investors cast 2.17 crore votes (12.75% of their category) against the resolution.
Promoter group and non-institutional public shareholders voted nearly 100% in favor of the transaction.
The resolution is deemed passed as of February 01, 2026, the final date of e-voting.
👀 What to Watch
Investors should view this as a positive step for operational synergy within the group's Bengaluru expansion. While the institutional dissent is minor, it is worth monitoring future related party disclosures for specific financial terms.
KIMS Seeks Shareholder Approval for ₹150 Cr Related Party Transaction with Bengaluru Subsidiary
Krishna Institute of Medical Sciences (KIMS) has issued a postal ballot notice to seek shareholder approval for material related party transactions with its subsidiary, KIMS Hospital Bengaluru Private Limited (KHBPL). The resolution proposes an aggregate transaction limit of up to ₹150 Crores, covering both existing and new contracts, including loans, until the Annual General Meeting in FY 2026-27. The company maintains that these transactions will be conducted at arm's length and in the ordinary course of business. Shareholders can participate in the remote e-voting process from January 3, 2026, to February 1, 2026.
Key Highlights
Proposed aggregate value for transactions with KIMS Hospital Bengaluru Private Limited is up to ₹150 Crores.
The approval covers transactions and loans to be entered into until the AGM of Financial Year 2026-27.
Cut-off date for determining member eligibility for e-voting was December 30, 2025.
E-voting period spans 30 days, concluding on February 1, 2026, at 5:00 PM IST.
👀 What to Watch
Investors should monitor the capital allocation to the Bengaluru subsidiary to ensure it translates into regional growth and improved consolidated margins. This is a standard regulatory requirement for material transactions with subsidiaries.
KIMS to Enter Tamil Nadu with 300-Bed Super Speciality Hospital in Chennai for Rs 300 Cr
Krishna Institute of Medical Sciences (KIMS) has signed a long-term lease agreement for 1.168 acres of land in Chennai to establish its first hospital in Tamil Nadu. The project involves setting up a 300-bed super speciality facility with an estimated investment of Rs 300 crore. This expansion is slated for completion within the next 36 months and will be funded through a mix of internal accruals and bank loans. As of September 2025, the company operates over 8,800 beds with an occupancy rate of approximately 51%.
Key Highlights
Proposed addition of approximately 300 beds in Chennai, marking the company's entry into Tamil Nadu.
Total project investment estimated at Rs 300 crore to be deployed over 36 months.
Funding to be sourced via a combination of bank loans and internal accruals.
The land is acquired on a long-term lease from Andhra Mahila Sabha in Raja Annamalai Puram.
Existing group capacity stands at 8,800+ beds with 51% occupancy as of H1FY26.
👀 What to Watch
Investors should monitor the project's execution timeline as this entry into the high-demand Chennai market could significantly boost long-term revenue. The capital expenditure is manageable given the company's scale, but occupancy ramp-up in the new geography will be a key metric to watch.
KIMS Increases Stake in Sunshine Hospital to 75.53% for Rs 148.09 Crore
Krishna Institute of Medical Sciences (KIMS) has increased its equity stake in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital), from 68.59% to 75.53%. The acquisition of the additional 6.94% stake was completed via a secondary cash purchase for approximately Rs 148.09 crore. Sunshine Hospital is a high-performing asset, reporting a turnover of Rs 597 crore in FY25, representing a 28.6% growth over the previous year. This move consolidates KIMS's control over a key revenue-generating entity focused on orthopedics and multi-specialty care.
Key Highlights
Acquired additional 6.94% stake in Sarvejana Healthcare for a cash consideration of Rs 148.09 crore
Total shareholding in the material subsidiary increased to 75.53% from 68.59%
Sunshine Hospital turnover grew significantly from Rs 464.20 crore in FY24 to Rs 597.00 crore in FY25
The acquisition was executed as a strategic investment through a secondary purchase based on a valuation report
Sunshine Hospital specializes in high-end healthcare including orthopedics, cardiology, and transplants
👀 What to Watch
Investors should view this as a positive move to consolidate ownership in a fast-growing and profitable subsidiary. The increased stake will lead to higher profit attribution to KIMS shareholders from the Sunshine Hospital business.
KIMS Commences Operations at 350-Bed Multi-Specialty Hospital in Bengaluru
Krishna Institute of Medical Sciences (KIMS) has officially commenced operations at its new 350-bed multi-specialty tertiary care hospital in Electronic City, Bengaluru, as of December 15, 2025. The facility is operated through its subsidiary, KIMS Hospital Bengaluru Private Limited, and is located within the PES University campus. This expansion significantly strengthens the company's footprint in the Karnataka healthcare market. The hospital will provide advanced services in high-margin specialties including Oncology, Organ Transplant, and Robotic Sciences.
Key Highlights
Commencement of operations at a new 350-bedded multi-specialty hospital on December 15, 2025
Strategically located at PES University campus in Electronic City, a major technology hub in Bengaluru
Focus on high-end tertiary care including Cardiac, Neuro, Oncology, and Organ Transplant services
Expansion executed through subsidiary KIMS Hospital Bengaluru Private Limited
Facility equipped with 24/7 emergency services and cutting-edge robotic surgery technology
👀 What to Watch
Investors should monitor the occupancy ramp-up and the impact of gestation costs on near-term margins. This expansion is a long-term value creator that enhances KIMS's competitive positioning in the high-demand Bengaluru market.
